Bombay Hospital Journal ContentsHomeArchivesSearchBooksFeedback


Home > Table of Contents > Case Reports
 
Primary Pancreatic Lymphoma
 
Urmi Chakravarty*, Shailesh Vartak*, Cusumma Chodankar**, Nilima Ranadive***
 

Primary lymphoma of the pancreas is an exceedingly rare lesion comprising less than 0.5% of all pancreatic tumours. Patients commonly present with abdominal pain. The clinical and radiological findings are not pathognomonic and diagnosis is established only after histopathologic examination. Majority of the primary lymphomas of the pancreas are non-Hodgkin’s lymphomas of the B cell type. This lesion responds well to aggressive chemotherapy and hence its important to differentiate it from pancreatic carcinoma because of the significant difference between the treatment and prognosis of the two lesions.

 
Introduction

Primary pancreatic lymphoma is a rare form of extranodal lymphoma comprising less than 0.5% of pancreatic tumours originating from the pancreatic parenchyma.1 Although rare, this particular neoplasm is amenable to treatment even in very advanced stages. The clinical and radiological findings are not pathognomonic and the diagnosis is established only after histopathologic examination.2 Abdominal pain is the commonest presenting feature (83%), followed by a palpable abdominal mass (58%) and weight loss (50%).3 In our case the presenting symptom was repeated episodes of unconciousness probably due to low blood glucose levels caused by destruction of the pancreatic tissue by the tumour infiltration.

 
Case Report

Our patient was a forty year old male who presented with fever of eight days duration and complaint of episodes of unconsciousness off and on. At the time of admission the patient was drowsy and investigations revealed random blood sugar levels of 40 mg%. The patient did not respond to intravenous glucose therapy and expired within four hours of hospital stay. An autopsy was performed.

The salient feature noted at autopsy was the presence of a large ill-defined intra-abdominal mass measuring 8 cm x 6 cm x 5 cm. The cut section was fleshy and only in a small area could normal appearing pancreatic tissue be appreciated (Fig. 1). There was no tumour involvement at any other site and neither was there any evidence of localized or generalized lymphadenopathy.

Multiple sections from the tumour mass were studied. Most of the sections showed a monotonous population of small round cells in sheets separated by sparse fibrous septae (Fig. 2). The cells had infiltrated the pancreatic parenchyma and only isolated foci of viable pancreatic acini were seen. The cells had scanty cytoplasm, the nuclear chromatin was coarse and prominent nucleoli were seen at few sites. Mitotic figures were scarce. On the basis of light microscopy the impression given was a low grade non-Hodgkin’s lymphoma of the pancreas.

Immunohistochemistry was done for confirming the diagnosis. Positivity for pan B cell markers was noted. On the basis of immunohistochemistry the tumour was typed as a primary low grade B cell lymphoma of the pancreas


Fig. 1 : Large fleshy white tumour mass replacing the entire pancreas. There is no evidence of any tumour involvement in any of the adjoining organs or regional lymph nodes.

Fig. 2 : H and E stained section showing small round cells in loose sheets separated by sparse fibrous septae (400 X).
 
Discussion

Primary neoplasms of the pancreas are most often adenocarcinomas. Non-Hodgkin’s lymphomas involving the pancreas are less common but well documented. Primary pancreatic lymphoma is an extremely rare neoplasm that may be confused with pancreatic adenocarcinoma.4 It is important to differentiate between treatment and prognosis of the two conditions. The age at presentation ranges from 37 to 74 years (our patient was 40 year old) and abdominal pain is the commonest presenting feature.5 However there are case reports where there is a mention of a clinical presentation in the form of a diabetic crisis. Since most of the case reports in literature mention a favourable outcome following treatment it is important to establish a definitive diagnosis for this disease, to remove the tumour and to treat the patient with appropriate chemotherapy.2,6

 
References
1. Boni L, Bevnevento A, Dionigi G, Cabrini L, Dionigi R. Primary pancreatic lymphoma. Surg Endosc 2002 Jul; 16 (7) : 1107-8.
2. Ezzat A, Jamshed A, Khafaga Y, et al. Primary pancreatic non Hodgkins lymphoma. J Clin Gastroenterol 1996 Sep.; 23 (2) : 109-12
3. Behrns KE, Sarr MG, Strickler JG. Pancreatic lymphoma - is it a surgical disease. Pancreas 1994 Sep; 9 (5) : 662-7.
4. Salvator JR, Cooper B, Shah I, Kummet T. Primary pancreatic lymphoma: a case report, literature review and proposal for nomenclature. Med Oncol 2000 Aug; 17 (3) : 237-47.
5. Bouvet M, Staerkel GA, Spitz FR, et al. Primary pancreatic lymphoma. Surgery 1998 Apr; 123 (4) : 382-90.
6. Popescu RA, Wotherspoon AC, Cunningham D. Local recurrence of primary pancreatic lymphoma 18 years after complete remission. Hematol Oncol 1998 Mar; 16 (1) : 29-32.
   
ANTIBIOTICS IN THE PREVENTION OF HEART ATTACKS

Reports from observational and experimental studies in human beings and animals have suggested a link between chronic infection with Chlamydia pneumoniae, an intracellular pulmonary bacterium, and cardiovascular disease. In the past year, data have emerged from three randomised trials of antichlamydial regimens. Collectively these trials exclude the possibility of all but small benefits of antichlamydial antibiotics in the secondary prevention of coronary heart disease and they encourage a critical reappraisal of the observational human evidence that started, and has helped to sustain, the hypothesis linking chlamydia and coronary heart disease.

None of the three trials reported large differences between the antibiotic-treated group and controls in the incidence of coronary heart disease endpoints.

These sobering trial data do not support a causal interpretation of associations reported between c pneumoniae markers and cardiovascular disease in observational studies.

Lancet, 2005; 330 : 365.

*Lecturer; **Associate Professor; ***Professor and Head; Department of Pathology,
Lokmanya Tilak Municipal Medical College and Lokmanya Tilak Municipal General Hospital, Sion, Mumbai - 400 022.